[HTML][HTML] Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world …
…, H Ben-Amram, K Beiruti, Y Batheesh… - …, 2021 - eurosurveillance.org
The BNT162b2 mRNA COVID-19 vaccine showed high efficacy in clinical trials but observational
data from populations not included in trials are needed. We describe immunogenicity …
data from populations not included in trials are needed. We describe immunogenicity …
Impact of age, gender, ethnicity and prior disease status on immunogenicity following administration of a single dose of the BNT162b2 mRNA Covid-19 Vaccine: real …
KA Jabal, H Ben-Amram, K Beiruti, Y Batheesh… - medRxiv, 2021 - medrxiv.org
The Pfizer Covid-19 vaccine showed high efficacy in clinical trials but observational data from
populations not included in trials are needed. We described immunogenicity 21 days post-…
populations not included in trials are needed. We described immunogenicity 21 days post-…
[HTML][HTML] Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel
…, K Hussein, H Dabaja-Younis… - Clinical Microbiology …, 2022 - Elsevier
Objectives We evaluated the antibody response to the BNT162B2 vaccine among healthcare
workers (HCWs) to identify factors associated with decreased immunogenicity. Methods …
workers (HCWs) to identify factors associated with decreased immunogenicity. Methods …
B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patients
Y Bathish, N Tuvia, E Eshel, T Tal Lange… - Human Vaccines & …, 2024 - Taylor & Francis
Patients on dialysis (PoD) are at high risk of severe morbidity and mortality from COVID-19.
Characterizing long-term vaccine immune responses in these patients will help optimize …
Characterizing long-term vaccine immune responses in these patients will help optimize …
Post-COVID-19 vaccine SARS-CoV-2 antibody investigation in healthcare professionals
Objectives: Main purpose of this study was evaluating inactive severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) vaccine subsequent anti-S1 IgG feedback and the …
syndrome coronavirus-2 (SARS-CoV-2) vaccine subsequent anti-S1 IgG feedback and the …
Feature selection for discovering distributional treatment effect modifiers
Y Chikahara, M Yamada… - Uncertainty in Artificial …, 2022 - proceedings.mlr.press
Finding the features relevant to the difference in treatment effects is essential to unveil the
underlying causal mechanisms. Existing methods seek such features by measuring how …
underlying causal mechanisms. Existing methods seek such features by measuring how …
[PDF][PDF] Impact of Age, Gender, post-infection and post-vaccination status on antibody response in COVID-19 patients
S Sadiq, M Khan, T Sadiq, S Orakzai… - J Pak Med …, 2022 - researchgate.net
Objective: To evaluate severe acute respiratory syndrome coronavirus-2 spike protein
antibodies against coronavirus disease-2019 in post-infection and post-vaccinated individuals. …
antibodies against coronavirus disease-2019 in post-infection and post-vaccinated individuals. …
[BOOK][B] Detection of Circulating Biomarkers with Gold-Based Nanoparticles and Optical Spectroscopy
RE Wilson Jr - 2021 - search.proquest.com
Gold nanoparticles (AuNPs) are remarkable agents for biological detection due to their
facile surface modification, optical enhancement, and biocompatibility. These characteristics …
facile surface modification, optical enhancement, and biocompatibility. These characteristics …
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership
Well-regulated clinical trials have shown FDA-approved COVID-19 vaccines to be immunogenic
and highly efficacious. We evaluated seroconversion rates in adults reporting ≥ 1 dose …
and highly efficacious. We evaluated seroconversion rates in adults reporting ≥ 1 dose …
SARS-CoV-2 Immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021: Implications for vaccination policy
KA Jabal, H Ben-Amram, K Beiruti, I Brimat, AA Saada… - medRxiv, 2021 - medrxiv.org
Between December 2020-March 2021 we measured anti-SARS-CoV-2 IgG titers post-vaccination
with the BNT162b2 vaccine among 725 Israeli hospital workers. Previously infected …
with the BNT162b2 vaccine among 725 Israeli hospital workers. Previously infected …
